SPONSORS FIRST. ALWAYS. Prior to joining CBSET, Laura spent 4 years at Charles River Laboratories, managing key accounts and delivering tailored research solutions to principal investigators, scientists, and executives. “Working with biotech, pharma, and academic researchers taught me to put the sponsor at the center of everything I do — prioritizing their research goals and timelines […]

Lisa joined CBSET in 2016 as a Clinical Veterinarian. She has worked in clinical veterinary medicine, academia, and industry for nearly 20 years – including Biotech, Pharma, Veterinary Medicine and CRO. She earned her Doctor of Veterinary Medicine (DVM) degree at Tufts University School of Veterinary Medicine. THINGS YOU SHOULD KNOW ABOUT DR. LISA E. […]

Dr. Ganesan joined CBSET in July 2023 as a Clinical Veterinarian. Previously, he was a Veterinarian/Lab Animal Resident at MIT’s Biomedical Engineering lab, and Clinical Veterinarian/Staff Scientist at National Institutes of Health (NIH). At CBSET, Suresh is responsible for performing veterinary exams, developing protocols, and ensuring regulatory compliance with applicable agencies, in addition to caring […]

Ellie joined CBSET in July 2024 as a Study Director. She was previously a postdoctoral associate at the University of Minnesota’s Department of Neurology (2021-24) and its Division of Infectious Disease (2020-21), piloting preclinical research and clinical development of advanced gene therapies. THINGS YOU SHOULD KNOW ABOUT ELLIE KHADIR She is an expert in small- […]

Jay joined CBSET in 2010. In his role as a preclinical Study Director, Jay is responsible for a quality system ensuring that safety studies at CBSET are duly designed, conducted, and documented to generate reliable data. As a Scientist II, he manages associate scientists, coordinates study planning, provides technical guidance and performs surgical procedures. Jay […]

Joining CBSET in 2023, Dr. Nicola Parry is a Diplomate of the American College of Veterinary Pathologists (ACVP). She comes to CBSET from Massachusetts Institute of Technology (MIT) where she was Chief of Comparative Pathology, managing research and diagnostic pathology support for both in­ house and external research groups. Prior to MIT, Dr. Parry was […]

David joined CBSET in 2017 as Senior Account Executive for Business Development. He has 30 years of biotech and pharma sales experience in therapeutic areas ranging from cardiology, infertility, and oncology to allergy/immunology and patient-reported outcomes. Previous employers include Bristol Meyers Squibb, EMD Serono and Schering-Plough, working within the major academic medical centers in New […]

Donald joined CBSET in 2021. A neuroscientist and safety pharmacologist with expertise in behavioral assessments, Dr. Hodges is toxicology study director for small-molecule and biologic preclinical therapeutic research at CBSET. In this role, he advises Sponsors about in vivo preclinical study design and FDA expectations. In particular, he assists Sponsors in developing safety assessment studies, including […]

Dr. Williams-Fritze joined CBSET in 2012. She is responsible for developing surgical models, performing procedures to meet Sponsors’ needs and ensuring regulatory compliance with applicable agencies, and overall management of the vivarium and oversight and training of CBSET’s technical staff. THINGS YOU SHOULD KNOW ABOUT DR. MISTY WILLIAMS-FRITZE She is a key opinion leader in […]

Michael joined CBSET in 2016 as Director of Business Development, bringing significant biomedical experience and specialized expertise to the role. Previously, he was employed by Neural Stem Cell Institute (NSCI), where he oversaw development of a cell-based therapy for macular degeneration under an award from the New York Stem Cell Foundation. THINGS YOU SHOULD KNOW […]